DDR1 and breast cancer: In addition, expression of DDR proteins, ERCC1 [141] and RAD51 [142], in dormant CTCs in blood samples of metastatic BC patients has a significant association with therapy failure, which is suggestive of enhanced DDR capacity, particularly base excision and homologous recombination repairs.